References
- Albèr C, Brandner BD, Björklund S, et al. (2013). Effects of water gradients and use of urea on skin ultrastructure evaluated by confocal Raman microspectroscopy. Biochim Biophys Acta – Biomembr 1828:2470–8.
- Ali A, Wahlgren M, Pedersen L, Engblom J. (2018). Will a water gradient in oral mucosa affect transbuccal drug absorption? J Drug Deliv Sci Technol 48:338–45.
- Andersson M, Greiff L, Ojeda P, Wollmer P. (2014). Barrier-enforcing measures as treatment principle in allergic rhinitis: a systematic review. Curr Med Res Opin 30:1131–7.
- Andersson M, Greiff L, Wollmer P. (2008). Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis. Acta Otolaryngol 128:666–9.
- Andersson M, Greiff L, Wollmer P. (2011). Effects of a topical microemulsion in house dust mite allergic rhinitis. Basic Clin Pharmacol Toxicol 108:146–8.
- Atkins P, De Paula J. (2006). Atkins’ physical chemistry. 8th ed. Oxford: Oxford University Press.
- Aulton ME. (2007). Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh: Churchill Livingstone.
- Björk E, Edman P. (1990). Characterization of degradable starch microspheres as a nasal delivery system for drugs. Int J Pharm 62:187–92.
- Björklund S, Engblom J, Thuresson K, Sparr E. (2010). A water gradient can be used to regulate drug transport across skin. J Control Release 143:191–200.
- Bronaugh RL, Stewart RF, Simon M. (1986). Methods for in vitro percutaneous absorption studies VII: use of excised human skin. J Pharm Sci 75:1094–7.
- Callens C, Pringels E, Remon JP. (2003). Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailability. Int J Pharm 250:415–22.
- Davis SS, Illum L. (2003). Absorption enhancers for nasal drug delivery. Clin Pharmacokinet 42:1107–28.
- Dawson RMC. (1986). Data for biochemical research. In: Dawson RMC, Eliott DC, M JK, eds. 3rd ed. New York: Oxfort University Press, 404.
- Diaz del Consuelo I, Pizzolato G-P, Falson F, et al. (2005). Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue. J Pharm Sci 94:2777–88.
- Downes AM, McDonald IW. (1964). The Chromium-51 complex of ethylenediamine tetraacetic acid as a soluble rumen marker. Br J Nutr 18:153–62.
- Duan X, Mao S. (2010). New strategies to improve the intranasal absorption of insulin. Drug Discov Today 15:416–27.
- Emberlin JC, Lewis RA. (2006). A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 22:275–85.
- Evans DF, Wennerström H. (1999). The Colloidal Domain: Where physics, chemistry, biology and technology meet. Weinheim: WILEY-VCH.
- Ghori MU, Mahdi MH, Smith AM, Conway BR. (2015). Nasal drug delivery systems: an overview. Am J Pharmacol Sci 3:110–9.
- Golander Y, DeWitte WJ. (1985). Xylometazoline hydrochloride. In: Florey K, ed. Analytical profiles of drug substances, excipients and related methodology. Cambridge: Academic Press, 135–56.
- Greiff L, Wollmer P, Andersson M, Persson C. (1994). Human nasal absorption of 51Cr-EDTA in smokers and control subjects. Clin Exp Allergy 24:1036–40.
- Greiff L, Wollmer P, Pipkorn U, Persson C. (1991). Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine. Thorax 46:630–2.
- Greiff L, Wollmer P, Svensson C, et al. (1993). Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax 48:648–50.
- Hansen K, Kim G, Desai K-G, et al. (2015). Feasibility investigation of cellulose polymers for mucoadhesive nasal drug delivery applications. Mol Pharmaceutics 12:2732–41.
- Illum L. (2003). Nasal drug delivery – possibilities, problems and solutions. J Control Release 87:187–98.
- Jadhav K, Gambhire NM, Shaikh MI, et al. (2007). Nasal drug delivery system-factors affecting and applications. CDTH 2:27–38.
- Josling P, Steadman S. (2003). Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 20:213–9.
- Kumar A, Pandey AN, Jain SK. (2016). Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Deliv 23:671–83.
- Lee CP, De Vrueh RLA, Smith PL. (1997). Selection of development candidates based measurements. Adv Drug Deliv Rev 23:47–62.
- Lee JW, Park JH, Robinson JR. (2000). Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89:850–66.
- Marshall P, Snaar JEM, Ng YL, et al. (2001). A novel application of NMR microscopy: Measurement of water diffusion inside bioadhesive bonds. Magn Reson Imaging 19:487–8.
- Marshall P, Snaar JEM, Ng YL, et al. (2004). Localised mapping of water movement and hydration inside a developing bioadhesive bond. J Control Release 95:435–46.
- Mortazavi SA, Smart JD. (1993). An investigation into the role of water movement and mucus gel dehydration in mucoadhesion. J Control Release 25:197–203.
- Nicolazzo JA, Reed BL, Finnin BC. (2003). The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J Pharm Sci 92:2399–410.
- Nielsen LS, Schubert L, Hansen J. (1998). Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. Eur J Pharm Sci 6:231–9.
- Ninni L, Camargo M, Meirelles A. (1999). Water activity in poly(ethylene glycol) aqueous solutions. Thermochim Acta 328:169–76.
- Pereswetoff-Morath L, Morath M. (1998). Microspheres as nasal drug delivery systems 1. Adv Drug Deliv Rev 29:185–94.
- Ritger PL, Peppas N. (1987). A simple equation for description of solute release. I. Fickian and non Fickian. J Control Release 5:23–6.
- Runnsjö A, Dabkowska AP, Sparr E, et al. (2016). Diffusion through pig gastric mucin: effect of relative humidity. PLoS One 11:e0157596
- Schwetz S, Olze H, Melchisedech S, et al. (2004). Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 130:979–84.
- Shojaei A. (1998). Buccal mucosa as a route for systemic drug delivery : a review epithelium lamina propria. J Pharm Pharm Sci 1:15–30.
- Smart JD. (2005). The basics and underlying mechanisms of mucoadhesion B. Adv Drug Deliv Rev 57:1556–68.
- Soane RJ, Frier M, Perkins AC, et al. (1999). Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm 178:55–65.
- Ugwoke MI, Agu RU, Verbeke N, et al. (2005). Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev 57:1640–65.
- Upadhyay S, Parikh A, Joshi P, et al. (2011). Intranasal drug delivery system – a glimpse to become maestro. J Appl Pharm Sci 1:34–44.
- Wadell C. (2002). Nasal Drug Delivery - In Vitro Studies on Factors Influencing Permeability and Implications on Absorption. [Internet]. Uppsala University; Available at: http://uu.diva-portal.org/smash/get/diva2:162191/FULLTEXT01.pdf